Metastatic breast cancer is a topic that doesn’t get nearly as much attention as it should, even though it can be the most dangerous. Often called stage 4 or advanced breast cancer, metastatic breast cancer occurs when cancer cells spread from the breast to other parts of the body. This can include the bones, liver, lungs, or brain. While significant progress has been made in early detection and treatment of primary breast cancer, metastatic breast cancer remains incurable, and its research continues to be underfunded.
If you or a loved one is affected by metastatic breast cancer, it can feel isolating and frustrating to see the majority of awareness campaigns and research funding focused on the early-stages of breast cancer. Understanding why metastatic breast cancer deserves more attention is crucial. And not just for those living with the disease, but for the future of cancer care overall.
Understanding Metastatic Breast Cancer
Metastatic breast cancer is different from early-stage breast cancer in quite a few ways. Many people are diagnosed with breast cancer in its early stages and undergo treatments such as surgery, radiation, and chemotherapy with the hope that they are cured. However, approximately 30 percent of these women will eventually experience metastasis, meaning the cancer returns in a new location and becomes stage 4. In some cases (although not as often), women are diagnosed with metastatic breast cancer from the start.
On average, life expectancy after a diagnosis is about three years. However, many women live much longer. But unlike early-stage breast cancer, treatment for metastatic disease is not aimed at a cure. Instead, treatments focus on slowing progression, managing symptoms, and improving quality of life. Patients often remain on therapy for the rest of their lives, which can be physically and emotionally exhausting.
Despite the severity of the disease, metastatic breast cancer research has historically received a fraction of the funding allocated to early-stage breast cancer. While it is critical to continue funding prevention, screening, and early treatment, metastatic breast cancer research is lagging behind and needs more attention and resources.
The Gap in Research Funding
So why is there such a large gap in research funding for this stage of breast cancer? Simply put, part of the reason there are funding disparities for metastatic breast cancer is because of the lack of awareness and attention.
The pink ribbon campaigns that dominate October’s Breast Cancer Awareness Month have done an incredible job raising awareness and money for breast cancer in general. They have encouraged millions of women to get screenings and helped reduce death rates from early-stage disease. This also means the disease often doesn’t have a chance to progress.
But the campaigns often emphasize survivorship and early detection, leaving those with metastatic disease feeling overlooked.
According to estimates, only a small portion of breast cancer research funding is dedicated specifically to metastatic breast cancer. This lack of funding translates into fewer treatment options, slower progress in understanding how the disease spreads, and a gap in education and support for patients.
Research for metastatic breast cancer is incredibly complex. Scientists are trying to understand how cancer cells leave the breast, survive in the bloodstream, and establish tumors in new organs (aka metastasis). This process is one of the main reasons breast cancer becomes lethal. The more we understand metastasis, the better we can develop treatments that extend life and improve outcomes. But without adequate funding, progress in these areas is slowed, leaving patients without new options.
Why It’s Often Overlooked
One of the reasons metastatic breast cancer receives less attention is that it’s not as common as early-stage breast cancer. Only about 6% to 10% of women are diagnosed with stage 4 cancer initially, though many more progress to stage 4 later. It also requires lifelong treatment. This makes it less appealing for campaigns that like to celebrate a “clear ending”, like ringing a bell after completing chemotherapy.
Another factor is survivorship language. Many awareness efforts focus on patients who beat cancer or are cured. This can make metastatic patients feel invisible. Terms like survivor or being cancer-free don’t apply to those living with stage 4. Many patients have voiced that they feel excluded from the conversation.
This lack of representation has real consequences. When metastatic patients are invisible in campaigns and discussions, fundraising and research priorities follow the same pattern. If the public does not know that metastatic breast cancer exists or how devastating it can be, there is less pressure on institutions and government agencies to allocate funds toward understanding and treating it.
Progress Is Being Made, But Slowly
Despite these challenges, there is progress. Organizations like the Breast Cancer Research Foundation have made metastatic breast cancer a focus. They fund projects that study the mechanisms of metastasis, identify new biomarkers, and test innovative therapies. For example, initiatives like the AURORA studies are building the largest databases of primary and metastatic tumors. These studies help researchers understand why cancer spreads and why certain tumors resist treatment.
Clinical trials for metastatic breast cancer are also becoming more sophisticated. New treatments, including targeted therapies and immunotherapy, are helping some patients live longer and with better quality of life. The five-year survival rate for metastatic patients has doubled in recent decades, showing that investment in research can and does make a difference.
However, these advancements are still limited by funding and awareness. Without more widespread recognition of metastatic breast cancer as a distinct and urgent challenge, progress will continue to be incremental.
How Awareness Impacts Research and Treatment
It’s important to remember that awareness campaigns do more than educate the public. They also drive funding and influence the priorities of research institutions and pharmaceutical companies. If metastatic breast cancer were more widely recognized, more money would flow into research for new treatments and patient support services.
In addition, awareness can improve patient care. Metastatic patients often have unique medical needs, including managing long-term side effects, navigating complex treatment plans, and addressing quality of life concerns. Healthcare providers and support organizations are more likely to respond effectively when there is public attention and advocacy for this population.
Patients and their families can also benefit from greater awareness. Feeling recognized and represented can both improve emotional well-being and foster a sense of community. Social support is a critical component of coping with metastatic breast cancer, and campaigns that highlight this stage of the disease can help patients feel less isolated.
What Can Be Done to Support Metastatic Breast Cancer Research
There are several ways that individuals and organizations can make a difference in metastatic breast cancer research. One of the most direct ways is through donations to research foundations that focus on metastatic disease. Every contribution, no matter the size, can help fund clinical trials, lab research, and patient support programs.
Advocacy is another powerful tool. Writing to elected officials, supporting legislation that increases cancer research funding, and participating in awareness campaigns can create systemic change. Even small actions, like sharing information about metastatic breast cancer on social media or encouraging friends to donate to specialized research, can make more of a difference than you think. It’s all about getting the word out there and getting people to realize that metastatic breast cancer research deserves to be funded properly.
Patients and caregivers can also participate in research directly. Many clinical trials and registries rely on volunteers to help scientists understand how the disease behaves in real life. This includes contributing samples, completing surveys, or enrolling in studies. This helps accelerate discoveries that could improve survival and treatment for everyone living with the disease.
The Human Impact of Neglect
It is easy to look at statistics and think about metastatic breast cancer as a number. But behind every diagnosis is a person whose life is affected every day. These patients face uncertainty, ongoing treatment, and the emotional burden of knowing that their disease is incurable.
Families are impacted too. Loved ones must navigate the healthcare system, manage caregiving responsibilities, and cope with the fear of loss. Without sufficient research, the options for patients and families remain limited, and the emotional toll is magnified.
By increasing attention and funding for metastatic breast cancer, we are not just investing in science. We are investing in people, in families, and in the hope that one day stage 4 cancer can become a manageable, chronic condition rather than a death sentence.
Why You Should Care
Even if you are not personally affected, metastatic breast cancer deserves attention. Awareness and funding influence the speed of scientific progress. Every breakthrough in understanding how cancer spreads has the potential to improve outcomes for everyone, not just those currently living with stage 4 disease.
The research also helps to inform early-stage treatments. By understanding what causes cancer to spread, researchers can develop strategies to prevent metastasis from occurring in the first place. This means that supporting metastatic breast cancer research benefits the entire breast cancer community.
Finally, this is a matter of fairness and representation. Patients with metastatic breast cancer should not be invisible in campaigns, discussions, or funding priorities. Recognizing their experiences is a crucial step toward equity in healthcare and research.
Why Metastatic Breast Cancer Research Deserves More Attention
By understanding the unique challenges of this progression, supporting dedicated research, and advocating for increased funding, we can help improve treatments, extend lives, and give patients and families the support they need.
Every step we take toward greater awareness and research funding is a step toward changing the narrative. What was once seen as a death sentence can one day become a chronic, but manageable, condition. And hopefully, we can get rid of it altogether. But that starts with bringing more attention, and care, into the mix.
*The information provided on this website is for informational and educational purposes only. It is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition. Reliance on any information provided by this website is solely at your own risk. The owners, contributors, authors, and publishers of this website are not liable for any losses, injuries, or damages arising from the use of the information on this website.*